https://www.selleckchem.com/pr....oducts/vanzacaftor.h
c inquiry and is an ideal setting for these investigations.Corticosteroid therapy is now recommended as a treatment in patients with severe COVID-19. But one key question is how to objectively identify severely ill patients who may benefit from such therapy. Here, we assigned 12,862 COVID-19 cases from 21 hospitals in Hubei Province equally to a training and a validation cohort. We found that a neutrophil-to-lymphocyte ratio (NLR) 6.11 at admission discriminated a higher risk for mortality. Importantly, however, corticosteroid
Like
Comment
Share
